8-K/A XBRL

FORM 8-K/A

Company: REGENERON PHARMACEUTICALS, INC.
Filed: September 8, 2023
Period of Report: June 9, 2023
Accession Number: 0001104659-23-099351

View Document ↗ View on SEC.gov ↗